Ignite Creation Date:
2024-05-06 @ 7:41 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06103370
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-26
First Post:
2023-10-23
Brief Title:
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
Sponsor:
Johns Hopkins University
Organization:
Johns Hopkins University
Study Overview
Official Title:
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to evaluate the effectiveness of a social network intervention to recruit people who inject drugs and their networks for HIV testing and linkage to HIV prevention and treatment services in Maryland Study aims are to determine the effectiveness of a social network driven intervention to increase
HIV testing primary
PrEP knowledge
Uptake of HIV services and pre-exposure prophylaxis PrEP
Uptake of medication for opioid use disorder MOUD initiation
Eligible participants who access syringe service programs SSPs serving two counties in Maryland and their risk network members NMs will be recruited using an established network inventory and coupon recruitment method When an index successfully recruits NMs the index-NM cluster will be randomized to either a peer-educator intervention arm or an equal-attention control arm Index participants randomized to the peer-educator intervention arm will complete a training program adapted with stakeholder input to context that emphasizes effective communication frequent HIV testing and awareness of evidence-based HIV prevention and treatment services An important innovation to the network intervention will be training indexes to use and distribute HIV self-test kits and naloxone to their NMs Index participants randomized to the equal-attention control arm will receive training sessions focused on the opioid overdose epidemic and will not include any training to serve as a peer educator All participants indexes and NMs will complete study assessments at baseline and at 3 and 9 months We will compare the peer-educator intervention group and the equal-attention control group on rates of HIV testing knowledge of PrEP options and resources and rates of initiation of HIV treatment PrEP and MOUD treatment since the previous assessment past 3 or 6 months
HIV testing primary
PrEP knowledge
Uptake of HIV services and pre-exposure prophylaxis PrEP
Uptake of medication for opioid use disorder MOUD initiation
Eligible participants who access syringe service programs SSPs serving two counties in Maryland and their risk network members NMs will be recruited using an established network inventory and coupon recruitment method When an index successfully recruits NMs the index-NM cluster will be randomized to either a peer-educator intervention arm or an equal-attention control arm Index participants randomized to the peer-educator intervention arm will complete a training program adapted with stakeholder input to context that emphasizes effective communication frequent HIV testing and awareness of evidence-based HIV prevention and treatment services An important innovation to the network intervention will be training indexes to use and distribute HIV self-test kits and naloxone to their NMs Index participants randomized to the equal-attention control arm will receive training sessions focused on the opioid overdose epidemic and will not include any training to serve as a peer educator All participants indexes and NMs will complete study assessments at baseline and at 3 and 9 months We will compare the peer-educator intervention group and the equal-attention control group on rates of HIV testing knowledge of PrEP options and resources and rates of initiation of HIV treatment PrEP and MOUD treatment since the previous assessment past 3 or 6 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01DA058387 | NIH | None | httpsreporternihgovquickSearchR01DA058387 |